Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway

Experimental and Molecular Pathology

Volumn 96, Issue 3, 2014, Pages 411-421

  Xiong, Dongmei ^a   Liou, Yulin ^a   Shu, Jing ^a   Li, Dan ^a   Zhang, Luyu ^a   Chen, Junxia ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer cells; EMT; ILK; Metastasis; Ribonuclease inhibitor

Indexed keywords

CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; MATRIGEL; PHALLOIDIN; RIBONUCLEASE INHIBITOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS POTENTIAL; MICROFILAMENT; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STAINING; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BLADDER CANCER CELLS; EMT; ILK; METASTASIS; RIBONUCLEASE INHIBITOR;

ANIMALS; CADHERINS; CARRIER PROTEINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84899876000     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.04.012     Document Type: Article

References (25)

1. Araki K., Shimura T., Suzuki H., Tsutsumi S., Wada W., Yajima T., Kobayahi T., Kubo N., Kuwano H. E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br. J. Cancer 2011, 105:1885-1893.
2. Chen J., Ou-Yang X., Gao J., Zhu J., He X., Rong J. Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials. Mol. Cell. Biochem. 2011, 349:83-95.
3. Edwards L.A., Woo J., Huxham L.A., Verreault M., Dragowska W.H., Chiu G., Rajput A., Kyle A.H., Kalra J., Yapp D., Yan H., Minchinton A.I., Huntsman D., Daynard T., Waterhouse D.N., Thiessen B., Dedhar S., Bally M.B. Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK). Mol. Cancer Ther. 2008, 7:59-70.
4. Edwards L.A., Ijichi K., Tanaka H., Fujii M., Hasegawa Y., Ogawa T., Murakami S., Kondo E., Nakanishi H. Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway. Br. J. Cancer 2012, 106:1196-1204.
5. Fan F., Samuel S., Evans K.W., Lu J., Xia L., Zhou Y., Sceusi E., Tozzi F., Ye X.C., Mani S.A., Ellis L.M. Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med. 2012, 1:5-16.
6. Gulhati P., Bowen K.A., Liu J., Stevens P.D., Rychahou P.G., Chen M., Lee E.Y., Weiss H.L., O'Connor K.L., Gao T., Evers B.M. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011, 71:3246-3256.
7. Jacobs B.L., Lee C.T., Montie J.E. Bladder cancer in 2010: how far have we come?. CA Cancer J. Clin. 2010, 60:244-272.
8. Jang M.J., Baek S.H., Kim J.H. UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction. Cancer Lett. 2011, 302:128-135.
9. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
10. Matsui Y., Assi K., Ogawa O., Raven P.A., Dedhar S., Gleave M.E., Salh B., So A.I. The importance of integrin-linked kinase in the regulation of bladder cancer invasion. Int. J. Cancer 2012, 130:521-531.
11. McConkey D.J., Choi W., Marquis L., Martin F., Williams M.B., Shah J., Svatek R., Das A., Adam L., Kamat A., Siefker-Radtke A., Dinney C. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 2009, 28:335-344.
12. McDonald P.C., Fielding A.B., Dedhar S. Integrin-linked kinase-essential roles in physiology and cancer biology. J. Cell Sci. 2008, 121:3121-3132.
13. Nekrasov A.N., Zinchenko A.A. Structural features of the interfaces in enzyme-inhibitor complexes. J. Biomol. Struct. Dyn. 2010, 28:85-96.
14. Netherton S.J., Bonni S. Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells. PLoS One 2010, 5:e13971.
15. Pan X., Xiong D., Yao X., Xin Y., Zhang L., Chen J. Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells. Int. J. Biochem. Cell Biol. 2012, 44:998-1008.
16. Radisky E.S., Radisky D.C. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15:201-212.
17. Schulte J., Weidig M., Balzer P., Richter P., Franz M., Junker K., Gajda M., Friedrich K., Wunderlich H., Östman A., Petersen I., Berndt A. Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem. Cell Biol. 2012, 138:847-860.
18. Shapiro R. Cytoplasmic ribonuclease inhibitor. Methods Enzymol. 2001, 341:611-628.
19. Szepeshazi K., Schally A.V., Keller G., Block N.L., Benten D., Halmos G., Szalontay L., Vidaurre I., Jaszberenyi M., Rick F.G. Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS-108]. Oncotarget 2012, 3:686-699.
20. Talbot L.J., Bhattacharya S.D., Kuo P.C. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int. J. Biochem. Mol. Biol. 2012, 3:117-136.
21. Tran M.N., Choi W., Wszolek M.F., Navai N., Lee I.L., Nitti G., Wen S., Flores E.R., Siefker-Radtke A., Czerniak B., Dinney C., Barton M., McConkey D.J. The p63 protein isoform δNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J. Biol. Chem. 2013, 288:3275-3288.
22. Valacca C., Bonomi S., Buratti E., Pedrotti S., Baralle F.E., Sette C., Ghigna C., Biamonti G. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J. Cell Biol. 2010, 191:87-99.
23. Yao X., Wang X., Wang Z., Dai L., Zhang G., Yan Q., Zhou W. Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma. OncoTargets Ther. 2012, 5:255-261.
24. Zheng X., Vittar N.B., Gai X., Fernandez-Barrena M.G., Moser C.D., Hu C., Almada L.L., McCleary-Wheeler A.L., Elsawa S.F., Vrabel A.M., Shire A.M., Comba A., Thorgeirsson S.S., Kim Y., Liu Q., Fernandez-Zapico M.E., Roberts L.R. The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism. PLoS One 2012, 7:e49581.
25. Zhu J., Pan X., Zhang Z., Gao J., Zhang L., Chen J. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Cell. Signal. 2012, 24:1323-1332.